US President Donald Trump on Monday said nine pharmaceutical manufacturers, including Sun Pharma, have reached agreements with his administration to lower prescription drug prices for Americans in line with the lowest prices paid in other developed nations
The agreements bring the total number of pharmaceutical manufacturers with most-favoured-nation (MFN) pricing deals with the administration to 26, covering 89% of the branded drug market, according to the White House.